High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab

Weber, Tobias; Boetticher, Benedikt; Mier, Walter; Sauter, Max; Kraemer, Susanne; Leotta, Karin; Keller, Armin; Schlegelmilch, Anne; Grosse-Hovest, Ludger; Jaeger, Dirk; Haberkorn, Uwe; Arndt, Michaela A. E.; Krauss, Juergen

dc.contributor.author	Große-Hovest, Ludger
dc.date.accessioned	2017-03-29T14:51:32Z
dc.date.available	2017-03-29T14:51:32Z
dc.date.issued	2016
dc.identifier.issn	1619-7089
dc.identifier.uri	http://hdl.handle.net/10900/75657
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00259-015-3175-6	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_01580
utue.publikation.seiten	489-498	de_DE
utue.personen.roh	Weber, Tobias
utue.personen.roh	Boetticher, Benedikt
utue.personen.roh	Mier, Walter
utue.personen.roh	Sauter, Max
utue.personen.roh	Kraemer, Susanne
utue.personen.roh	Leotta, Karin
utue.personen.roh	Keller, Armin
utue.personen.roh	Schlegelmilch, Anne
utue.personen.roh	Grosse-Hovest, Ludger
utue.personen.roh	Jaeger, Dirk
utue.personen.roh	Haberkorn, Uwe
utue.personen.roh	Arndt, Michaela A. E.
utue.personen.roh	Krauss, Juergen
dcterms.isPartOf.ZSTitelID	European Journal of Nuclear Medicine and Molecular Imaging	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	43	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE